The FDA approved the first new class of antibiotics for treating urinary tract infections in nearly 30 years, with GSK’s pill Blujepa targeting E. coli bacteria resistant to standard antibiotics. UTIs are common and can lead to complications if untreated, making new treatment options crucial. Blujepa was successful in clinical trials and is expected to be available later this year, although the cost may be higher than generic options.
Full Article
“Multiple system failures” led to door plug flying off Alaska Airlines flight in 2024, NTSB chair says
The NTSB has issued safety recommendations to the FAA and Boeing following a January 2024 incident where a door plug detached from an Alaska Airlines flight, causing minor injuries to eight passengers. The NTSB attributed the accident to Boeing's inadequate training and oversight, combined with the FAA's ineffective compliance enforcement, leading to a lawsuit from affected passengers. Explain It To Me Like I'm 5: The National Transportation Safety Board found that a door on an...
Read more